2024-513639-26-00已完成1 期
A Study to Investigate Single Ascending Doses of Ocrelizumab for Safety and Side Effects, How The Body Handles It Over A Period of Time, How The Body Notices and Reacts To It, And Its Effect On The Body When Given As A Subcutaneous Injection In Patients With Multiple Sclerosis
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 44
- 试验地点
- 14
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Trial Information System - TISL
Scientific
F. Hoffmann-La Roche AG
研究点 (14)
Loading locations...
相似试验
尚未招募
不适用
Ondansetrin in pediatruc GastroentritisAcute gastroentritis in children.Viral intestinal infection, unspecifiedA08.4IRCT20220128053852N1Esfahan University of Medical Sciences30
招募中
1 期
A single- and multiple ascending dose study of KP-910 in healthy adult males and healthy elderly males.JPRN-jRCT2071230041Murakami Harumi96
已完成
1 期
A single and multiple ascending dose study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of AZP-3813, a growth hormone antagonist, in healthy subjectsAcromegaly2023-503734-47-00Amolyt Pharma, Amolyt Pharma101
招募中
1 期
An ascending single and multiple dose study of the safety, tolerability, pharmacokinetics and anti-tumour activity of once-daily oral treatment with EO1001 in patients with advanced cancer.ACTRN12620000583943Senz Oncology Pty Ltd50
已完成
1 期
An Open-label, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of LYN-163 in Healthy VolunteersInfection - Other infectious diseasesMalariaACTRN12621001218886yndra®Therapeutics, Inc. (Lyndra)15